KalVista Pharmaceuticals (KALV) Operating Margin (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 39,675.00 |
| Apr 30, 2020 | 57,262.00 |
| Jan 31, 2020 | -56,988.00 |
| Oct 31, 2019 | 4,692.00 |
| Jul 31, 2019 | 10,094.00 |
| Apr 30, 2019 | -21,362.00 |
| Jan 31, 2019 | -8,371.00 |
| Oct 31, 2018 | 10,102.00 |
| Jul 31, 2018 | -12,717.00 |
| Apr 30, 2018 | 12,510.00 |
| Jan 31, 2018 | 34,035.00 |
| Oct 31, 2017 | 515,341.00 |
| Jul 31, 2017 | -121,880.00 |
| Apr 30, 2017 | -118,842.00 |
| Jan 31, 2017 | -122,984.00 |
| Oct 31, 2016 | -151,802.00 |
| Mar 31, 2016 | -1.37 Mn |
| Dec 31, 2015 | -957,143.00 |
| Sep 30, 2015 | 1.10 Mn |
| Jun 30, 2015 | -1.09 Mn |
| Sep 30, 2014 | 1.30 Mn |
| Jun 30, 2014 | -1.78 Mn |